Semin Respir Crit Care Med 2003; 24(2): 137-150
DOI: 10.1055/s-2003-39029
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Genetic Epidemiological Approaches to the Study of Lung Disease

Benjamin A. Rybicki
  • Department of Biostatistics and Research Epidemiology, Henry Ford Health System, Detroit, Michigan
Further Information

Publication History

Publication Date:
07 May 2003 (online)

ABSTRACT

The DNA sequence data provided by the Human Genome Project offer great promise in the prevention and treatment of lung disease in the new millennium. Making sense of these data with regard to how they relate to disease susceptibility and progression will require new and innovative genetic epidemiological approaches. Although tried and true methodologies such as case-control comparisons are still useful, a better understanding of genotype-phenotype relationships in lung disease can be gained by comparisons across similar diseases, such as the HLA-DPB1 associations observed in both berylliosis and sarcoidosis. Study of gene-environment and gene-gene interactions in lung disease is critical to the understanding of pathogenic processes in the lung such as localized inflammation and malignant transformation. Oligonucleotide microarray studies of gene expression in the lung are well under way and promise to uncover numerous previously unknown genetic factors involved in lung pathogenesis. One of the greatest challenges facing genetic epidemiologists studying lung disease in the new millennium will be how to translate the myriad results from microarray and similar data-driven technologies into information useful to the medicine practiced in pulmonary clinics.

REFERENCES

  • 1 Crystal R G. Research opportunities and advances in lung disease.  JAMA . 2001;  285 612-618
  • 2 Collins F S, McKusick V A. Implications of the Human Genome Project for medical science.  JAMA . 2001;  285 540-544
  • 3 Noone P G, Knowles M R. "CFTR-opathies": disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations.  Respir Res . 2001;  2 328-332
  • 4 Payan D G. Neuropeptides and inflammation: the role of substance P.  Ann Rev Med . 1989;  40 341-352
  • 5 Hinman L M, Stevens C, Matthay R A, Gee J BL. Angiotensin convertase activities in human alveolar macrophages: effects of smoking and sarcoidosis.  Science . 1979;  205 201-203
  • 6 Weinstock J V, Blum A M, Kassab J T. Angiotensin II is chemotactic for a T-cell subset which can express migration inhibition factor activity in murine schistosomiasis mansoni.  Cell Immunol . 1987;  107 180-187
  • 7 Yosipiv I V, Dipp S, el-Dahr S S. Ontogeny of somatic angiotensin-converting enzyme.  Hypertension . 1994;  23 369-374
  • 8 Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.  J Clin Invest . 1990;  86 1343-1346
  • 9 Schunkert H. Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease.  J Mol Med . 1997;  75 867-875
  • 10 Planck A, Eklund A, Yamaguchi E, Grunewald J. Angiotensin-converting enzyme gene polymorphism in relation to HLA-DR in sarcoidosis.  J Intern Med . 2002;  251 217-222
  • 11 McGrath D S, Foley P J, Petrek M. et al . Ace gene I/D polymorphism and sarcoidosis pulmonary disease severity.  Am J Respir Crit Care Med . 2001;  164 197-201
  • 12 Pietinalho A, Furuya K, Yamaguchi E, Kawakami Y, Selroos O. The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients.  Eur Respir J . 1999;  13 723-726
  • 13 Maliarik M J, Rybicki B A, Malvitz E. et al . Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis.  Am J Respir Crit Care Med . 1998;  158 1566-1570
  • 14 Niimi T, Tomita H, Sato S. et al . Bronchial responsiveness and angiotensin-converting enzyme gene polymorphism in sarcoidosis patients.  Chest . 1998;  114 495-499
  • 15 Benessiano J, Crestani B, Mestari F. et al . High frequency of a deletion polymorphism of the angiotensin-converting enzyme gene in asthma.  J Allergy Clin Immunol . 1997;  99 53-57
  • 16 Chagani T, Pare P D, Zhu S. et al . Prevalence of tumor necrosis factor-alpha and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma.  Am J Respir Crit Care Med . 1999;  160 278-282
  • 17 Lee Y C, Cheon K T, Lee H B, Kim W, Rhee Y K, Kim D S. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with asthma.  Allergy . 2000;  55 959-963
  • 18 Morimoto S, Okaishi K, Onishi M. et al . Deletion allele of the angiotensin-converting enzyme gene as a risk factor for pneumonia in elderly patients.  Am J Med . 2002;  112 89-94
  • 19 Arbustini E, Grasso M, Leo G. et al . Polymorphism of angiotensin-converting enzyme gene in sarcoidosis.  Am J Respir Crit Care Med . 1996;  153 851-854
  • 20 Tomita H, Ina Y, Sugiura Y. et al . Polymorphism in the angiotensin-converting enzyme (ACE) gene and sarcoidosis.  Am J Respir Crit Care Med . 1997;  156 255-259
  • 21 Rossman M D, Kern J A, Elias J A. et al . Proliferative response of bronchoalveolar lymphocytes to beryllium: a test for chronic beryllium disease.  Ann Intern Med . 1988;  108 687-693
  • 22 Rossman M D, Jones-Williams W. Immunopathogenesis of chronic beryllium disease. In: Rossman MD, Preuss OP, Powers MB, eds. Beryllium: Biomedical and Environmental Aspects Baltimore: Williams & Wilkins 2002: 121-132
  • 23 Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.  Science . 1993;  262 242-244
  • 24 Lombardi G, Germain C, Uren J. et al . HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease.  J Immunol . 2001;  166 3549-3555
  • 25 Fontenot A P, Torres M, Marshall W H, Newman L S, Kotzin B L. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.  Proc Natl Acad Sci USA . 2000;  97 12717-12722
  • 26 Amicosante M, Sanarico N, Berretta F. et al . Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69.  Hum Immunol . 2001;  62 686-693
  • 27 Maliarik M J, Chen K M, Major M L. et al . Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis.  Am J Respir Crit Care Med . 1998;  158 111-114
  • 28 Schurmann M, Lympany P A, Reichel P. et al . Familial sarcoidosis is linked to the major histocompatibility complex region.  Am J Respir Crit Care Med . 2000;  162 861-864
  • 29 Lympany P A, Petrek M, Southcott A M, Newman T A, Welsh K I, Du B R. HLA-DPB polymorphisms: Glu 69 association with sarcoidosis.  Eur J Immunogenet . 1996;  23 353-359
  • 30 Brand C R. Relations between emotional and social behaviour: a questionnaire study of individual differences.  Br J Soc Clin Psychol . 1972;  11 10-19
  • 31 Murin S, Hilbert J, Reilly S J. Cigaret smoking and the lung.  Clin Rev Allergy Immunol . 1997;  15 307-361
  • 32 Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950; combination of national statistics with two case-control studies.  BMJ . 2000;  321 323-329
  • 33 Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose.  Cancer Res . 1991;  51 5177-5180
  • 34 Zhou W, Liu G, Miller D P. et al . Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer.  Cancer Res . 2002;  62 1377-1381
  • 35 Wang Z, Chen C, Niu T. et al . Association of asthma with beta(2)-adrenergic receptor gene polymorphism and cigarette smoking.  Am J Respir Crit Care Med . 2001;  163 1404-1409
  • 36 Wilkinson R J, Pasvol G. Tuberculosis, HIV, hormones and children.  J R Coll Physicians Lond . 1995;  29 86-88
  • 37 Rockett K A, Brookes R, Udalova I, Vidal V, Hill A V, Kwiatkowski D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line.  Infect Immun . 1998;  66 5314-5321
  • 38 Wilkinson R J, Llewelyn M, Toossi Z. et al . Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study.  Lancet . 2000;  355 618-621
  • 39 Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing.  Stat Med . 1990;  9 811-818
  • 40 Weinberg C R, Umbach D M. Choosing a retrospective design to assess joint genetic and environmental contributions to risk.  Am J Epidemiol . 2000;  152 197-203
  • 41 Piegorsch W W, Weinberg C R, Taylor J A. Nonhierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies.  Stat Med . 1994;  13 153-162
  • 42 Garcia-Closas M, Rothman N, Lubin J. Misclassification in case-control studies of gene-environment interactions: assessment of bias and sample size.  Cancer Epidemiol Biomarkers Prev . 1999;  8 1043-1050
  • 43 Albert P S, Ratnasinghe D, Tangrea J, Wacholder S. Limitations of the case-only design for identifying gene-environment interactions.  Am J Epidemiol . 2001;  154 687-693
  • 44 Schmidt S, Schaid D J. Potential misinterpretation of the case-only study to assess gene-environment interaction.  Am J Epidemiol . 1999;  150 878-885
  • 45 Forey B. International smoking statistics: a collection of historical data from 30 economically developed countries. 2nd ed. New York: Oxford University Press; 2002
  • 46 Nyberg F, Isaksson I, Harris J R, Pershagen G. Misclassification of smoking status and lung cancer risk from environmental tobacco smoke in never-smokers.  Epidemiology . 1997;  8 304-309
  • 47 Suadicani P, Hein H O, Gyntelberg F. Mortality and morbidity of potentially misclassified smokers.  Int J Epidemiol . 1997;  26 321-327
  • 48 Rybicki B A, Elston R C. The relationship between the sibling recurrence-risk ratio and genotype relative risk.  Am J Hum Genet . 2000;  66 593-604
  • 49 Risch N, Merikangas K. The future of genetic studies of complex human diseases.  Science . 1996;  273 1516-1517
  • 50 Schliekelman P, Slatkin M. Multiplex relative risk and estimation of the number of loci underlying an inherited disease.  Am J Hum Genet . 2002;  71 1369-1385
  • 51 Haagerup A, Bjerke T, Schiotz P O, Binderup H G, Dahl R, Kruse T A. Asthma and atopy: a total genome scan for susceptibility genes.  Allergy . 2002;  57 680-686
  • 52 Haagerup A, Bjerke T, Schoitz P O, Binderup H G, Dahl R, Kruse T A. Allergic rhinitis: a total genome-scan for susceptibility genes suggests a locus on chromosome 4q24-q27.  Eur J Hum Genet . 2001;  9 945-952
  • 53 Greenwood C M, Fujiwara T M, Boothroyd L J. et al . Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family.  Am J Hum Genet . 2000;  67 405-416
  • 54 Bellamy R, Beyers N, McAdam K P. et al . Genetic susceptibility to tuberculosis in Africans: a genome-wide scan.  Proc Natl Acad Sci USA . 2000;  97 8005-8009
  • 55 Broman K W, Murray J C, Sheffield V C, White R L, Weber J L. Comprehensive human genetic maps: individual and sex-specific variation in recombination.  Am J Hum Genet . 1998;  63 861-869
  • 56 Kong A, Gudbjartsson D F, Sainz J. et al . A high-resolution recombination map of the human genome.  Nat Genet . 2002;  31 241-247
  • 57 Dib C, Faure S, Fizames C. et al . A comprehensive genetic map of the human genome based on 5,264 microsatellites.  Nature . 1996;  380 152-154
  • 58 Sachidanandam R, Weissman D, Schmidt S C. et al . A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms.  Nature . 2001;  409 928-933
  • 59 Huttley G A, Smith M W, Carrington M, O'Brien S J. A scan for linkage disequilibrium across the human genome.  Genetics . 1999;  152 1711-1722
  • 60 Rybicki B A, Iyengar S K, Harris T. et al . The distribution of long range admixture linkage disequilibrium in an African-American population.  Hum Hered . 2002;  53 187-196
  • 61 Dunning A M, Durocher F, Healey C S. et al . The extent of linkage disequilibrium in four populations with distinct demographic histories.  Am J Hum Genet . 2000;  67 1544-1554
  • 62 Wilson J F, Goldstein D B. Consistent long-range linkage disequilibrium generated by admixture in a Bantu-Semitic hybrid population.  Am J Hum Genet . 2000;  67 926-935
  • 63 Immervoll T, Loesgen S, Dutsch G. et al . Fine mapping and single nucleotide polymorphism association results of candidate genes for asthma and related phenotypes.  Hum Mutat . 2001;  18 327-336
  • 64 Chapman N H, Wijsman E M. Genome screens using linkage disequilibrium tests: optimal marker characteristics and feasibility.  Am J Hum Genet . 1998;  63 1872-1885
  • 65 Fallin D, Cohen A, Essioux L. et al . Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease.  Genome Res . 2001;  11 143-151
  • 66 Fallin D, Schork N J. Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data.  Am J Hum Genet . 2000;  67 947-959
  • 67 Daly M J, Rioux J D, Schaffner S F, Hudson T J, Lander E S. High-resolution haplotype structure in the human genome.  Nat Genet . 2001;  29 229-232
  • 68 Yu A, Zhao C, Fan Y. et al . Comparison of human genetic and sequence-based physical maps.  Nature . 2001;  409 951-953
  • 69 Mohrenweiser H W, Tsujimoto S, Gordon L, Olsen A S. Regions of sex-specific hypo- and hyper-recombination identified through integration of 180 genetic markers into the metric physical map of human chromosome 19.  Genomics . 1998;  47 153-162
  • 70 Przeworski M, Wall J D. Why is there so little intragenic linkage disequilibrium in humans?.  Genet Res . 2001;  77 143-151
  • 71 Johnson G C, Esposito L, Barratt B J. et al . Haplotype tagging for the identification of common disease genes.  Nat Genet . 2001;  29 233-237
  • 72 Comstock M L. Diesel exhaust in the occupational setting: current understanding of pulmonary health effects.  Clin Lab Med . 1998;  18 767-779
  • 73 Gift J S, Faust R A. Noncancer inhalation toxicology of crystalline silica: exposure-response assessment.  J Expo Anal Environ Epidemiol . 1997;  7 345-358
  • 74 Nyberg B F, Pershagen G. Epidemiologic studies on the health effects of ambient particulate air pollution.  Scand J Work Environ Health . 2000;  26 (suppl 1) S49-s89
  • 75 Duhme H, Weiland S K, Keil U. Epidemiological analyses of the relationship between environmental pollution and asthma.  Toxicol Lett . 1998;  102-103 307-316
  • 76 Gerin M, Siemiatycki J, Kemper H, Begin D. Obtaining occupational exposure histories in epidemiologic case-control studies.  J Occup Med . 1985;  27 420-426
  • 77 Rybicki B A, Peterson E L, Johnson C C, Kortsha G X, Cleary W M, Gorell J M. Intra- and inter-rater agreement in the assessment of occupational exposure to metals.  Int J Epidemiol . 1998;  27 269-273
  • 78 Tang D, Santella R M, Blackwood A M. et al . A molecular epidemiological case-control study of lung cancer.  Cancer Epidemiol Biomarkers Prev . 1995;  4 341-346
  • 79 Tang D, Phillips D H, Stampfer M. et al . Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study.  Cancer Res . 2001;  61 6708-6712
  • 80 Bartsch H, Rojas M, Alexandrov K, Risch A. Impact of adduct determination on the assessment of cancer susceptibility.  Recent Results Cancer Res . 1998;  154 86-96
  • 81 Pastorelli R, Guanci M, Cerri A. et al . Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide.  Cancer Epidemiol Biomarkers Prev . 1998;  7 703-709
  • 82 Grunstein M, Hogness D S. Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene.  Proc Natl Acad Sci USA . 1975;  72 3961-3965
  • 83 Gieser P, Bloom G C, Lazaridis E N. Introduction to microarray experimentation and analysis.  Methods Mol Biol . 1902;  184 29-49
  • 84 Mariani T J, Reed J J, Shapiro S D. Expression profiling of the developing mouse lung: insights into the establishment of the extracellular matrix.  Am J Respir Cell Mol Biol . 2002;  26 541-548
  • 85 Kaplan F, MacRae T, Comber J. et al . Application of expression microarrays to the investigation of fetal lung development in a glucocorticoid receptor knockout mouse model.  Chest . 2002;  121 (suppl 3) S90
  • 86 Prince L S, Karp P H, Moninger T O, Welsh M J. KGF alters gene expression in human airway epithelia: potential regulation of the inflammatory response.  Physiol Genomics . 2001;  6 81-89
  • 87 Hong T M, Yang P C, Peck K. et al . Profiling the downstream genes of tumor suppressor PTEN in lung cancer cells by complementary DNA microarray.  Am J Respir Cell Mol Biol . 2000;  23 355-363
  • 88 Manganelli R, Voskuil M I, Schoolnik G K, Dubnau E, Gomez M, Smith I. Role of the extracytoplasmic-function sigma Factor sigmaH in Mycobacterium tuberculosis global gene expression.  Mol Microbiol . 2002;  45 365-374
  • 89 Betts J C, Lukey P T, Robb L C, McAdam R A, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling.  Mol Microbiol . 2002;  43 717-731
  • 90 Wilson M, DeRisi J, Kristensen H H. et al . Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization.  Proc Natl Acad Sci USA . 1999;  96 12833-12838
  • 91 Oh J M, Brichory F, Puravs E. et al . A database of protein expression in lung cancer.  Proteomics . 2001;  1 1303-1319
  • 92 Miura K, Bowman E D, Simon R. et al . Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles.  Cancer Res . 2002;  62 3244-3250
  • 93 Bremnes R M, Veve R, Gabrielson E. et al . High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.  J Clin Oncol . 2002;  20 2417-2428
  • 94 Nadadur S S, Schladweiler M C, Kodavanti U P. A pulmonary rat gene array for screening altered expression profiles in air pollutant-induced lung injury.  Inhal Toxicol . 2000;  12 1239-1254
  • 95 Leikauf G D, McDowell S A, Wesselkamper S C. et al . Acute lung injury: functional genomics and genetic susceptibility.  Chest . 2002;  121 S70-S75
  • 96 Wuju L, Momiao X. Tclass: tumor classification system based on gene expression profile.  Bioinformatics . 2002;  18 325-326
  • 97 Tsodikov A, Szabo A, Jones D. Adjustments and measures of differential expression for microarray data.  Bioinformatics . 2002;  18 251-260
  • 98 Xiong M, Jin L, Li W, Boerwinkle E. Computational methods for gene expression-based tumor classification.  Biotechniques . 2000;  29 1264-1270
  • 99 Zhang H, Yu C Y, Singer B, Xiong M. Recursive partitioning for tumor classification with gene expression microarray data.  Proc Natl Acad Sci USA . 2001;  98 6730-6735
  • 100 Datta S. Exploring relationships in gene expressions: a partial least squares approach.  Gene Expr . 1902;  9 249-255
  • 101 Park P J, Pagano M, Bonetti M. A nonparametric scoring algorithm for identifying informative genes from microarray data.  Pac Symp Biocomput . 1902;  52-63
  • 102 Thomas J G, Olson J M, Tapscott S J, Zhao L P. An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles.  Genome Res . 2001;  11 1227-1236
  • 103 Nguyen D V, Rocke D M. Tumor classification by partial least squares using microarray gene expression data.  Bioinformatics . 2002;  18 39-50
  • 104 Ghosh D, Chinnaiyan A M. Mixture modelling of gene expression data from microarray experiments.  Bioinformatics . 2002;  18 275-286
    >